ARTICLE | Company News
Archemix, Ribomic Inc. deal
August 18, 2008 7:00 AM UTC
The partners expanded a 2006 deal to give Ribomic a non-exclusive, worldwide license to use Archemix’s aptamer technology to develop aptamer therapeutics against undisclosed targets. The original deal...